COVID-19: Discharge status, ICU admission, Intubation, Medications, Lab results

Citation Author(s):
Fatemeh
Samieerad
Ali
Sajadi
Sajad
Shafiekhani
Nematollah
Gheibi
Ensiyeh
Bahadoran
Manijeh
Jalilvand
Abbas
Allami
Peyman
Namdar
Zahra
Hosseinkhani
Hasan
Farahani
Submitted by:
ensiyeh bahadoran
Last updated:
Sun, 11/12/2023 - 04:09
DOI:
10.21227/f4fm-n714
License:
0
0 ratings - Please login to submit your rating.

Abstract 

Data on 2355 COVID-19 cases by date of July to December 2021 were extracted from a data set recorded by COVID-19 referral centers at Qazvin province in Iran. We recorded a wide range of clinical characteristics including age, sex, previous diseases, and hospitalization time. Moreover, we collected data about the different consumed medications including Atrovastatin 20 mg, Atrovastatin 40 mg, Ivermectin 3 mg, Ivermectin 40 mg, Dexamethasone, Kaletra, Favipiravir, Famotidine 40 mg, Interferon, Remdesivir, Hydroxychloroquine. Also, we monitored laboratory markers during the time, including WBC, MCH, MCV, MCHC, Neutrophil, Lymphocyte, RDW-CV, Mono blast, Plt Count, BUN, Cr, Na, and K. 

Instructions: 

Extract the Zip file.

Comments

excelllent

Submitted by SAHIL SINHA on Wed, 10/18/2023 - 04:47

very good

Submitted by sameh Mohsen on Tue, 01/09/2024 - 08:26